companydata.dkcompanydata.dk

Olfarma ApS: Financial statements 2024

CVR: 40241167

Source: annual report 2024, Danish Business Authority

01/01/202431/12/2024

Olfarma ApS (CVR 40241167) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 497,895 and a net result of DKK 59,935 compared with DKK -13,807 the year before. That is an increase of 22.1% compared with the year before. Equity in the 2024 report amounted to DKK 271,092. The solvency ratio was 31.9%. The company had 2 employees in the financial year.

Gross Profit
DKK 497,895
Profit/Loss
DKK 59,935
Equity
DKK 271,092
Total Assets
DKK 850,960
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-498 t.60 t.271 t.2
2023-408 t.-14 t.211 t.1
2022-445 t.43 t.225 t.-
2021-73 t.40 t.86 t.-
202087 t.39 t.29 t.46 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Olfarma ApS: The 2023 annual report is outJun 28, 2024

Olfarma ApS has published its annual report for 2023. Gross profit came to DKK 407,839, and the net result was DKK -13,807.

About Olfarma ApS

Olfarma ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jørgen Claus Oldenburg. The company is owned by Jørgen Claus Oldenburg and Anne Merete Oldenburg. According to the 2025 annual report, the company had an average of 2 employees. In 2025, the company reported a gross profit of DKK 686,093 and a net result of DKK 14,104 compared with DKK 59,935 the year before. Equity in the 2025 report amounted to DKK 285,196.

Source: annual report 2025, Danish Business Authority

Other financial years